PARTNER HOSPITALSPlan a visit
Xinhua Hospital, SJTU School of Medicine
Grade-A Tertiary · Pediatric Flagship Shanghai
RetinoblastomaPediatric OncologyPerinatal Medicine
Established
1958
Beds
2,300+
Annual visits
4,000,000+
About the Hospital
Xinhua Hospital's pediatric arm runs the world's largest retinoblastoma intra-arterial chemotherapy program — led by Prof. Zhao Peiquan — achieving survival above 99% with around 80% eye preservation, alongside a complete pediatric oncology and perinatal medicine platform.
Highlights
- World's largest retinoblastoma IAC center
- Rb survival >99% · eye preservation ~80%
- JAMA Ophthalmology-published research team
Our Specialists
Specialty Centers
Key Figures
>99%
Retinoblastoma survival
~80%
Eye preservation rate
JAMA Ophth.
Research published
International Patient Services
- Superselective intra-arterial chemotherapy program
- Vision rehabilitation & survivorship clinics
- Genetic counseling for heritable retinoblastoma
- Bilingual structured reports
- Long-term remote follow-up
Condition
RetinoblastomaBrain tumorNeonatal care
